Skip to main content
John Hornberger, MD, Internal Medicine, San Francisco, CA

JohnCarlHornbergerMDMS FACP

Internal Medicine San Francisco, CA


Senior Clinical Researcher, Acumen, LLC Adjunct Clinical Professor of Medicine, Stanford University

Dr. Hornberger is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hornberger's full profile

Already have an account?

Education & Training

  • Stanford Health Care
    Stanford Health CarePost-Doctoral Fellowship, Health Services Research, 1988 - 1992
  • Stanford Health Care
    Stanford Health CareFellowship, Nephrology, 1989 - 1991
  • Stanford University
    Stanford UniversityM.S., Health Services Research, 1991
  • Stanford Health Care
    Stanford Health CareResidency, Internal Medicine, 1987 - 1989
  • Stanford Health Care
    Stanford Health CareInternship, Internal Medicine, 1985 - 1986
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1985
  • University of CaliforniaB.A., Mathematics, Cum Laude, 1979

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2021 - 2022
  • NC State Medical License
    NC State Medical License 2020 - Present
  • CA State Medical License
    CA State Medical License 1987 - 2022
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Fellow American College of Physicians, 2013
  • Picker/Commonwealth Scholars Award Commonwealth Fund, 1993
  • Alpha Omega Alpha Honor Society University of Rochester, New York, 1985
  • Join now to see all

Publications & Presentations


Journal Articles

  • Economic Analysis of a Noninvasive Molecular Pathologic Assay for Pigmented Skin Lesions  
    John Hornberger, MD, JAMA
  • Assigning value to medical algorithms - implications for personalized medicine  
    Hornberger J, Personalized Medicine, 1/1/2013
  • Impact of a genomic classifier of metastatic risk on postoperative treatment recommendations for prostate cancer patients: a report from the DECIDE study group  
    Badani K, Thompson DJS, Buerki C, Davicioni E, Garrison J, Ghadessi M, Mitra MP, Wood PJ, Hornberger J, Oncotarget, 1/1/2013
  • Join now to see all

Books/Book Chapters

  • Join now to see all


  • How are coverage decisions made in publicly-funded healthcare programs in low- and middle-income countries?
    Hornberger J, Shewade A, Gutierrez H, International Society for Pharmacoeconomic and Outcomes Research (ISPOR) 16th Annual International Meeting, Baltimore, MD, 1/1/2011
  • Economic impact of rituximab as maintenance therapy in previously untreated follicular non-Hodgkin lymphoma.
    Hornberger J, Friedmann M, Han L, Chien R, Hornberger R, Satram-Hoang S, Reyes C, CAJ Clin Oncol, 1/1/2011
  • Cost-effectiveness of febuxostat in managing hyperuricemia in gout patients in Canada.
    Redding L, Hornberger J, Cowen JW, Chien R, Wang M, Annual Conference of Canadian Association of Population Therapeutics, Ottawa, Canada, 1/1/2011
  • Join now to see all


  • Payment Reform in the United States – A Town-Hall Meeting of the American Society of Clinical Oncology 
    Chicago, IL - 5/31/2014
  • The Biggest Threat to Personalized Medicine – Not Paying For Algorithms 
    Silicon Valley, Mountainview, CA - 1/28/2013
  • Reimbursement – The Good, the Bad, and the Ugly 
    Boston, MA - 9/4/2012
  • Join now to see all


  • National forecasts of ADAP expenditures. 
    Hornberger J, Chun R, MaCurdy T
  • Fiscal implications of Salt Lake County’s Health Access Project: A Hospital Perspective. 
    Hornberger J, Rapoport D, Marrufo G, HRSA
  • Master's Thesis: “High-flux dialysis: A technology assessment” 
    Hornberger J, Stanford University

Press Mentions

  • DermTech Announces the Publication of a Health Economic and Utility Study of the PLA in JAMA Dermatology
    DermTech Announces the Publication of a Health Economic and Utility Study of the PLA in JAMA DermatologyJuly 11th, 2018

Grant Support

  • Modeling Outcomes In Renal Replacement TherapyNational Institute Of Diabetes And Digestive And Kidney Diseases1994–1995


  • Member, Ethics, American Society of Clinical Oncology 2012 - Present

Professional Memberships

Other Languages

  • Spanish